Assignee
NOVAROCK BIOTHERAPEUTICS LTD
US·3 granted patents·8 pending applications·3 citations·filing 2020–2025
Top patents by PatentIndex Score
11 records- 0192US11407828B2Anti-CLauDiN 18 antibodies and methods of use thereofNOVAROCK BIOTHERAPEUTICS LTD·Filed 2020·Granted Aug 9, 2022·3 cites·5 claims
- 0273US12365727B2Anti-interleukin-23 P19 antibodies and methods of use thereofNOVAROCK BIOTHERAPEUTICS LTD·Filed 2022·Granted Jul 22, 2025·0 cites·17 claims
- 0372US2023272063A1Anti-claudin 18 antibodies and methods of use thereofNOVAROCK BIOTHERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 0471US2023067757A1Anti-claudin 18 antibodies and methods of use thereofNOVAROCK BIOTHERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 0566US11396541B2Anti-interleukin-23 P19 antibodies and methods of use thereofNOVAROCK BIOTHERAPEUTICS LTD·Filed 2020·Granted Jul 26, 2022·0 cites·13 claims
- 0660US2024383978A1Bispecific binding proteins that bind cd137 and a tumor associated antigenNOVAROCK BIOTHERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 0759US2025002599A1Bispecific and trispecific binding proteins to pd-l1, cd137, and/or tgf-beta and uses thereofNOVAROCK BIOTHERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 0857US2026078179A1Cdh17 antibodies and uses thereofNOVAROCK BIOTHERAPEUTICS LTD·Filed 2025·Application pending·0 cites
- 0956US2025277026A1Antibodies against claudin-6 and uses thereofNOVAROCK BIOTHERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 1054US2023331867A1Nectin-4 antibodies and uses thereofNOVAROCK BIOTHERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1153US2024067740A1Antibodies to tnfr2 and uses thereofNOVAROCK BIOTHERAPEUTICS LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NOVAROCK BIOTHERAPEUTICS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →